Traws PharmaTRAW
13F holders, Q1 2024 (March 31)26holders
2famous investors
$1.01avg. 13F price*
At the end of Q1 2024, 26 institutions reported holding Traws Pharma Inc. (TRAW) in their 13F filings. The largest holders were Vanguard Group Inc. ($716K), Renaissance Technologies ($271K) and BlackRock Inc. ($251K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Traws Pharma Inc.
- Filed as
- ONCONOVA THERAPEUTICS INC (Q1 2024)
- CUSIP
- 68232V801
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $38K |
| Exits | 5 | $25K |
Ownership 26 holders
| Vanguard Group Inc. | 0.00% | No change | 708,618 | $716K |
| Renaissance Technologies | 0.00% | Add +34.9% | 268,194 | $271K |
| BlackRock Inc. | 0.00% | Reduce 0.0% | 248,878 | $251K |
| Geode Capital Management, LLC | 0.00% | No change | 192,858 | $195K |
| Marex Group Ltd | 0.00% | No change | 148,023 | $150K |
| Two Sigma Advisers, LP | 0.00% | Reduce -6.3% | 73,066 | $74K |
| State Street Corp. | 0.00% | No change | 52,790 | $53K |
| Two Sigma Investments, LP | 0.00% | Reduce -3.6% | 37,987 | $38K |
| Citadel Advisors | 0.00% | New | 36,819 | $37K |
| Northern Trust Corp. | 0.00% | No change | 30,783 | $31K |
| Morgan Stanley | 0.00% | No change | 18,855 | $19K |
| Beacon Pointe Advisors, LLC | 0.00% | Reduce -51.7% | 13,776 | $14K |
| Mutual Advisors, LLC | 0.00% | No change | 12,700 | $13K |
| Edmond DE Rothschild Holding S.A. | 0.00% | No change | 6,666 | $7K |
| Vermillion & White Wealth Management Group, LLC | 0.00% | No change | 5,133 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -1.8% | 3,487 | $4K |
| Group One Trading LLC | 0.00% | No change | 1,613 | $2K |
| FMR LLC | 0.00% | New | 1,000 | $1K |
| UBS Group AG | 0.00% | Reduce -96.6% | 263 | $266 |
| Towne Trust Company, N.A | 0.00% | New | 166 | $168 |
| Wells Fargo & Company | 0.00% | Add +1.9% | 164 | $166 |
| JPMorgan Chase & Co. | 0.00% | Add +41.7% | 51 | $52 |
| Cornerstone Planning Group LLC | 0.00% | New | 33 | $21 |
| Osaic Holdings, Inc. | 0.00% | Add +150.0% | 10 | $10 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $3 |
| Royal Bank of Canada | 0.00% | Reduce -67.8% | 128 | $0 |
"% of holder's portfolio" is TRAW's weight in each manager's 13F, not the share of Traws Pharma Inc. the manager owns.